This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dipika Sarkar: Innovator in Non-Alcoholic Fatty Liver Disease Treatment
Introduction
Dipika Sarkar is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). Her innovative work has the potential to impact many lives positively.
Latest Patents
Dipika Sarkar holds a patent for "Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof." This patent includes compounds that inhibit or modulate the Ubiquitin Ligase COP1 enzyme, which can produce a physiologically beneficial response. The compounds are designed to increase the level of adipose triglyceride lipase (ATGL), thereby aiding in the treatment of NAFLD.
Career Highlights
Dipika is associated with the Council of Scientific and Industrial Research, where she has been involved in groundbreaking research. Her dedication to scientific advancement has led to her recognition in the field of medical innovation.
Collaborations
Some of her notable coworkers include Nirmal Das and Subrata Das, who have collaborated with her on various research projects.
Conclusion
Dipika Sarkar's contributions to the treatment of non-alcoholic fatty liver disease through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to inspire future research and development in this critical area of health.